Intellia Therapeutics, Inc. Cambridge, MA
Intellia is at the forefront of the promising crisPr/cas9 technology which can delete, insert and modify the DNA sequences of cells. With incredible potential to cure human genetic diseases, the company was founded in 2014 by Atlas Venture and Caribou Biosciences.
R E Dinneen was invited to design their new office and lab facilities. Intellia chose a speculative lab space designed by R E Dinneen for MitiMco real estate. the space is open with a lot of natural light. Private offices are glass enclosed, as well as general meeting areas, gathering spaces and the transition from the offices to research labs. Bright orange accent walls provide visual interest. the research labs include analytics and tissue culture.